NOVARTIS PHARMA: all contributions
2025–2026 · Reported individual contributions grouped by employer.
These are contributions by individuals, not by their employer, industry, or location. Refunds remain negative; memo-only rows are marked and are not additional money.
← Back to NOVARTIS PHARMA| # | Reported contributor / location | Reported employer / occupation | Recipient / reporting committee | Date ↕ | Amount ↑ | Election | Filing details / source |
|---|---|---|---|---|---|---|---|
| 1 | KRAMHOELLER, ERIKAVON LAKEOH44012 | PHARMA SALES MANAGERNOVARTIS PHARMA | FRIENDS OF SHERROD BROWNC00916288 | 2026-05-11 | $100 | General 2026 (G2026) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1997409FEC filing ↗ |
| 2 | BENDISKE, JENNIFERGOSHENNY10924 | PROGRAM MANAGERNOVARTIS PHARMA | TALARICO FOR TEXASC00919084 | 2026-05-27 | $250 | General 2026 (G2026) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1997887FEC filing ↗ |
| 3 | BENDISKE, JENNIFERGOSHENNY10924 | PROGRAM MANAGERNOVARTIS PHARMA | ACTBLUEC00401224 | 2026-05-27 | $250 | Primary (P) | EARMARKED FOR TALARICO FOR TEXAS (C00919084)Filing 1986105FEC filing ↗ |
One page is fetched at a time, with one extra row to check for the next page. Current amendment versions are selected before pagination. Raw reported names and filing values are preserved. This list covers locally ingested FEC individual-contribution records, not undisclosed or unitemized contributor identities.